Home
Resources
Publications
A Highly Potent and Selective Vps34 Inhibitor Alters Vesicle Trafficking and Autophagy

A Highly Potent and Selective Vps34 Inhibitor Alters Vesicle Trafficking and Autophagy

Baptiste Ronan, Odile Flamand, Lionel Vescovi, Christine Dureuil, Laurence Durand, Florence Fassy, Marie-France Bachelot, Annabelle Lamberton, Magali Mathieu, Thomas Bertrand, Jean-Pierre Marquette, Youssef El-Ahmad, etc.

Nat Chem Biol. 2014 Dec;10(12):1013-9.

PMID: 25326666

Abstract:

Vps34 is a phosphoinositide 3-kinase (PI3K) class III isoform that has attracted major attention over the recent years because of its role in autophagy. Herein we describe the biological characterization of SAR405, which is a low-molecular-mass kinase inhibitor of Vps34 (KD 1.5 nM). This compound has an exquisite protein and lipid kinase selectivity profile that is explained by its unique binding mode and molecular interactions within the ATP binding cleft of human Vps34. To the best of our knowledge, this is the first potent and specific Vps34 inhibitor described so far. Our results demonstrate that inhibition of Vps34 kinase activity by SAR405 affects both late endosome-lysosome compartments and prevents autophagy. Moreover, we show that the concomitant inhibition of Vps34 and mTOR, with SAR405 and the US Food and Drug Administration-approved mTOR inhibitor everolimus, results in synergistic antiproliferative activity in renal tumor cell lines, indicating a potential clinical application in cancer.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
IAR42416324	VPS34 human			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: